Short-Term Treatment with Diminazene Aceturate Ameliorates the Reduction in Kidney ACE2 Activity in Rats with Subtotal Nephrectomy

Angiotensin-Converting Enzyme 2 Decreases Formation and Severity of Angiotensin II–Induced Abdominal Aortic Aneurysms

(2014) Sean E. Thatcher et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

ACE2: Angiotensin II/Angiotensin-(1–7) Balance in Cardiac and Renal Injury

(2014) Jasmina Varagic et al.   CURRENT HYPERTENSION REPORTS

Angiotensin-Converting Enzyme 2–Independent Action of Presumed Angiotensin-Converting Enzyme 2 Activators

(2014) Philipp K. Haber et al.   HYPERTENSION

Angiotensin-(1-7) Augments Endothelium-dependent Relaxations of Porcine Coronary Arteries to Bradykinin by Inhibiting Angiotensin-Converting Enzyme 1

(2014) Gábor Raffai et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

ACE2 activation by xanthenone prevents leptin-induced increases in blood pressure and proteinuria during pregnancy in Sprague-Dawley rats

(2014) Hisham Saleh Ibrahim et al.   REPRODUCTIVE TOXICOLOGY

Diminazene Attenuates Pulmonary Hypertension and Improves Angiogenic Progenitor Cell Functions in Experimental Models

(2013) Vinayak Shenoy et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Diminazene Aceturate Enhances Angiotensin-Converting Enzyme 2 Activity and Attenuates Ischemia-Induced Cardiac Pathophysiology

(2013) YanFei Qi et al.   HYPERTENSION

High urinary ACE2 concentrations are associated with severity of glucose intolerance and microalbuminuria

(2012) Se Eun Park et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Increased Urinary Angiotensin-Converting Enzyme 2 in Renal Transplant Patients with Diabetes

(2012) Fengxia Xiao et al.   PLoS One

Oral administration of an angiotensin-converting enzyme 2 activator ameliorates diabetes-induced cardiac dysfunction

(2012) Tatiane M. Murça et al.   REGULATORY PEPTIDES

Chronic kidney disease: cardiac and renal angiotensin-converting enzyme (ACE) 2 expression in rats after subtotal nephrectomy and the effect of ACE inhibition

(2011) L. M. Burrell et al.   EXPERIMENTAL PHYSIOLOGY

Expression of ACE and ACE2 in Patients with Hypertensive Nephrosclerosis

(2011) Gang Wang et al.   KIDNEY & BLOOD PRESSURE RESEARCH

Urinary angiotensin-converting enzyme 2 in patients with CKD

(2011) SONOO MIZUIRI et al.   NEPHROLOGY

ACE2–angiotensin-(1–7)–Mas axis in renal ischaemia/reperfusion injury in rats

(2010) Kátia D. da Silveira et al.   CLINICAL SCIENCE

Angiotensin-(1–7) infusion is associated with increased blood pressure and adverse cardiac remodelling in rats with subtotal nephrectomy

(2010) Elena Velkoska et al.   CLINICAL SCIENCE

Prevention of Angiotensin II–Mediated Renal Oxidative Stress, Inflammation, and Fibrosis by Angiotensin-Converting Enzyme 2

(2010) JiuChang Zhong et al.   HYPERTENSION

Reduction in renal ACE2 expression in subtotal nephrectomy in rats is ameliorated with ACE inhibition

(2009) Elena Velkoska et al.   CLINICAL SCIENCE

Human Recombinant ACE2 Reduces the Progression of Diabetic Nephropathy

(2009) G. Y. Oudit et al.   DIABETES

Expression of ACE and ACE2 in Individuals With Diabetic Kidney Disease and Healthy Controls

(2008) Sonoo Mizuiri et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Acute kidney injury in the rat causes cardiac remodelling and increases angiotensin-converting enzyme 2 expression

(2008) L. Burchill et al.   EXPERIMENTAL PHYSIOLOGY

Structure-Based Identification of Small-Molecule Angiotensin-Converting Enzyme 2 Activators as Novel Antihypertensive Agents

(2008) José A. Hernández Prada et al.   HYPERTENSION